Optikos® will present its full portfolio of optical capabilities at Photonics West 2026 between January 20th and 22nd in San ...
The Electric solar wind Sail doctors (E-Sailors) is a challenge-based Doctoral Network that aims to bring Electric solar wind sail (E-sail) from low Earth orbit (LEO) demonstration missions to the ...
CEA-Leti has collaborated with STMicroelectronics to unveil a major step toward practical, continuous biochemical monitoring: a wearable patch prototype that analyzes sweat in real time.
The Global Wide Bandgap Semiconductor Market Size projected to grow at a CAGR of 12.6% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that the ...
As Google’s AI Overviews answer more queries directly, vibe coding gives marketers a way to create interactive experiences AI ...
More than $463 million in state funding has been allocated to pay for some 400 projects across New York state and projects in Westchester are due to receive about $8.8 million of the total.
To fully utilize the popular science value of the aforementioned high-end resources, the school has explored a construction mode for the popular science base that integrates “Resource Sharing, ...
Bipolar Disorder, Digital Phenotyping, Multimodal Learning, Face/Voice/Phone, Mood Classification, Relapse Prediction, T-SNE, Ablation Share and Cite: de Filippis, R. and Al Foysal, A. (2025) ...
This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...
Silvercorp Metals is pleased to report the results of its PEA for the Condor gold project in Ecuador. The PEA is based on the Mineral Resource Estimate which was prepared for the Project in accordance ...
Introduction This article outlines the research protocol for a multicentre, randomised, controlled study designed to evaluate the therapeutic effect of a modified olfactory training (MOT) based on ...
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...